Andreas Fibig to leave Bayer HealthCare Pharmaceuticals
30-May-2014
- Germany
"With his experience and his commitment, Andreas Fibig has advanced the very positive development of our Pharmaceuticals business over the past years making it to one of the fastest growing pharmaceutical companies in the industry," said Olivier Brandicourt, CEO of Bayer HealthCare. "We thank him and wish him all the best for his next step in his career and his future."
The company will announce a successor for Andreas Fibig in a few days.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.